Points-to-consider: the mRNA vaccine reflection paper

  • YAMAGUCHI Teruhide
    Kanazawa-Institute of Technology, 7-1 Ohgigaoka, Nonoichi, Ishikawa 921-8501, Japan Nihon Pharmaceutical University, 210281 Komuro, Inamachi Kitaadachi-gun, Saitama 362-006, Japan Japan Pharmaceuticals and Medical Devices Agency, Shi-Kasumigaseki Bldg, 3-3-2 kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan
  • OGAWA Takashi
    Japan Pharmaceuticals and Medical Devices Agency, Shi-Kasumigaseki Bldg, 3-3-2 kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan
  • ANDO Tsuyoshi
    Japan Pharmaceuticals and Medical Devices Agency, Shi-Kasumigaseki Bldg, 3-3-2 kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan
  • YOSHIDA Satoshi
    Japan Pharmaceuticals and Medical Devices Agency, Shi-Kasumigaseki Bldg, 3-3-2 kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan
  • SAKURAI Akira
    Japan Pharmaceuticals and Medical Devices Agency, Shi-Kasumigaseki Bldg, 3-3-2 kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan
  • MAKI Kazushige
    Japan Pharmaceuticals and Medical Devices Agency, Shi-Kasumigaseki Bldg, 3-3-2 kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan
  • ARAKI Yasuhiro
    Japan Pharmaceuticals and Medical Devices Agency, Shi-Kasumigaseki Bldg, 3-3-2 kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan

収録刊行物

参考文献 (24)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ